CVE-2023-26913 — MEDIUM (6.1)

Q: What is CVE-2023-26913?

CVE-2023-26913 is a vulnerability with a CVSS score of 6.1 (MEDIUM). EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

Q: How severe is CVE-2023-26913?

CVE-2023-26913 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2023-26913?

Check the references section above for vendor advisories and patch information. Affected products include: Evolucare Ecs Imaging.

Vulnerability Description

EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

CVSS Score

6.1

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

CHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
Evolucare	Ecs Imaging	6.21.5

Related Weaknesses (CWE)

CWE-79

References

https://wanheiqiyihu.top/2023/02/13/Evolucare-Ecsimaging-new-movie-php%E5%8F%8D%ExploitThird Party Advisory
https://wanheiqiyihu.top/2023/02/13/Evolucare-Ecsimaging-new-movie-php%E5%8F%8D%ExploitThird Party Advisory

FAQ

What is CVE-2023-26913?

CVE-2023-26913 is a vulnerability with a CVSS score of 6.1 (MEDIUM). EVOLUCARE ECSIMAGING (aka ECS Imaging) < 6.21.5 is vulnerable to Cross Site Scripting (XSS) via new_movie. php.

How severe is CVE-2023-26913?

CVE-2023-26913 has been rated MEDIUM with a CVSS base score of 6.1/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-26913?

Check the references section above for vendor advisories and patch information. Affected products include: Evolucare Ecs Imaging.